Medison Pharma Announces Extension of Multi-territorial Agreement with Immunocore and Expansion into Australia and New Z

a global pharma company focused on providing access to highly innovative therapies to patients in...

Related Keywords

Australia ,United States ,New Zealand ,United Kingdom ,Israel ,Canada ,Toronto ,Ontario ,Switzerland ,Cyprus ,Greece ,Prnewswire Medison Pharma ,Medison Pharma ,Immunocore Imm ,Gil Gurfinkel ,Meir Jakobsohn ,Drug Administration ,Nasdaq ,Vp Corporate Development At Medison ,Maya Nixcorporate Communications ,European Union ,Immunocore Holdings ,European Medicines Agency ,Central Eastern Europe ,Breakthrough Therapy Designation ,Fast Track ,Accelerated Assessment ,Promising Innovative Medicine ,United Kingdom Early Access ,Medicines Scheme ,Release Syndrome ,Prescribing Information ,Maya Nixcorporate Communications Lead ,